Skip to main content
Erschienen in: Wiener klinisches Magazin 3/2014

01.06.2014 | Chirurgie

Funktionserhalt und Funktionsverbesserung in der onkologischen Leberchirurgie

verfasst von: R. Öllinger, Prof. Dr. J. Pratschke, FACS

Erschienen in: Wiener klinisches Magazin | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die onkologische Leberchirurgie ist für primäre Malignome der Leber wie auch Lebermetastasen der einzige kurative Ansatz. Resektionen an der Leber, die vor einigen Jahren noch als undenkbar galten, sind heute aufgrund von Fortschritten in Technik, Diagnostik, Patientenmanagement und -selektion sowie durch multimodale Konzepte erfolgreiche kurative Ansätze. Während heute weder für pharmakologische Interventionen zur Funktionsverbesserung der Leber noch für die Leberersatztherapie überzeugende Daten vorliegen, sind Leberfunktionstests, präoperative Maßnahmen (Cholangiodrainage, Pfortaderembolisation/-ligatur) und eine patientenadaptierte Operationsplanung für diese Therapieansätze maßgebend. Limitierender Faktor ist neben den anatomischen Voraussetzungen v. a. die Leberfunktion.
Literatur
1.
Zurück zum Zitat Eveno C, Karoui M, Gayat E et al (2013) Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections. HPB (Oxford) 15:359–364 Eveno C, Karoui M, Gayat E et al (2013) Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections. HPB (Oxford) 15:359–364
2.
Zurück zum Zitat Haas RJ de, Wicherts DA, Flores E et al (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248:626–637PubMed Haas RJ de, Wicherts DA, Flores E et al (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248:626–637PubMed
3.
Zurück zum Zitat Dejong CHC (2013) Vascular reconstruction combined with liver resection for malignant tumours (Br J Surg 2013; 100: 1764–1775). Br J Surg 100:1776PubMedCrossRef Dejong CHC (2013) Vascular reconstruction combined with liver resection for malignant tumours (Br J Surg 2013; 100: 1764–1775). Br J Surg 100:1776PubMedCrossRef
4.
Zurück zum Zitat Truant S, Oberlin O, Sergent G et al (2007) Remnant liver volume to body weight ratio < or = 0.5 %: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204:22–33PubMedCrossRef Truant S, Oberlin O, Sergent G et al (2007) Remnant liver volume to body weight ratio < or = 0.5 %: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204:22–33PubMedCrossRef
5.
Zurück zum Zitat Okochi O, Kaneko T, Sugimoto H et al (2002) ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 103:109–113PubMedCrossRef Okochi O, Kaneko T, Sugimoto H et al (2002) ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 103:109–113PubMedCrossRef
6.
Zurück zum Zitat Zipprich A, Kuss O, Rogowski S et al (2010) Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 59:963–968PubMedCrossRef Zipprich A, Kuss O, Rogowski S et al (2010) Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 59:963–968PubMedCrossRef
7.
Zurück zum Zitat Stockmann M, Lock JF, Riecke B et al (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 250:119–125PubMedCrossRef Stockmann M, Lock JF, Riecke B et al (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 250:119–125PubMedCrossRef
8.
Zurück zum Zitat Denys A, Prior J, Bize P et al (2012) Portal vein embolization: what do we know? Cardiovasc Intervent Radiol 35:999–1008PubMedCrossRef Denys A, Prior J, Bize P et al (2012) Portal vein embolization: what do we know? Cardiovasc Intervent Radiol 35:999–1008PubMedCrossRef
9.
Zurück zum Zitat Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364–372PubMedCentralPubMedCrossRef Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364–372PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Simoneau E, Aljiffry M, Salman A et al (2012) Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford) 14:461–468 Simoneau E, Aljiffry M, Salman A et al (2012) Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford) 14:461–468
11.
Zurück zum Zitat Ardito F, Vellone M, Barbaro B et al (2013) Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence. Surgery 153:801–810PubMedCrossRef Ardito F, Vellone M, Barbaro B et al (2013) Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence. Surgery 153:801–810PubMedCrossRef
12.
Zurück zum Zitat Sala S, Ardiles V, Ulla M et al (2012) Our initial experience with ALPPS technique: encouraging results. Updates Surg 64:167–172PubMedCrossRef Sala S, Ardiles V, Ulla M et al (2012) Our initial experience with ALPPS technique: encouraging results. Updates Surg 64:167–172PubMedCrossRef
13.
Zurück zum Zitat Shindoh J, Vauthey J-N, Zimmitti G et al (2013) Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 217:126–133 (discussion133–134)PubMedCrossRef Shindoh J, Vauthey J-N, Zimmitti G et al (2013) Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 217:126–133 (discussion133–134)PubMedCrossRef
14.
Zurück zum Zitat Richardson AJ, Laurence JM, Lam VWT (2014) Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB (Oxford) 16:12–19 Richardson AJ, Laurence JM, Lam VWT (2014) Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB (Oxford) 16:12–19
15.
Zurück zum Zitat Gurusamy KS, Kumar Y, Pamecha V et al (2009) Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database Syst Rev (1):CD007629 Gurusamy KS, Kumar Y, Pamecha V et al (2009) Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion. Cochrane Database Syst Rev (1):CD007629
16.
Zurück zum Zitat Lam VWT, Laurence JM, Johnston E et al (2013) A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford) 15:483–491 Lam VWT, Laurence JM, Johnston E et al (2013) A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford) 15:483–491
17.
Zurück zum Zitat Eisele RM, Zhukowa J, Chopra S et al (2010) Results of liver resection in combination with radiofrequency ablation for hepatic malignancies. Eur J Surg Oncol 36:269–274PubMedCrossRef Eisele RM, Zhukowa J, Chopra S et al (2010) Results of liver resection in combination with radiofrequency ablation for hepatic malignancies. Eur J Surg Oncol 36:269–274PubMedCrossRef
18.
Zurück zum Zitat Kerkhove M-P van de, Jong KP de, Rijken AM et al (2003) MARS treatment in posthepatectomy liver failure. Liver Int 23(Suppl 3):44–51PubMedCrossRef Kerkhove M-P van de, Jong KP de, Rijken AM et al (2003) MARS treatment in posthepatectomy liver failure. Liver Int 23(Suppl 3):44–51PubMedCrossRef
Metadaten
Titel
Funktionserhalt und Funktionsverbesserung in der onkologischen Leberchirurgie
verfasst von
R. Öllinger
Prof. Dr. J. Pratschke, FACS
Publikationsdatum
01.06.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinisches Magazin / Ausgabe 3/2014
Print ISSN: 1869-1757
Elektronische ISSN: 1613-7817
DOI
https://doi.org/10.1007/s00740-014-0218-8

Weitere Artikel der Ausgabe 3/2014

Wiener klinisches Magazin 3/2014 Zur Ausgabe

Aktuell

ECCMID

Panorama

Panorama